All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F12%3A33141661" target="_blank" >RIV/61989592:15310/12:33141661 - isvavai.cz</a>

  • Result on the web

    <a href="http://benthamscience.com/contents-JCode-MRMC-Vol-00000012-Iss-00000012.htm" target="_blank" >http://benthamscience.com/contents-JCode-MRMC-Vol-00000012-Iss-00000012.htm</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells

  • Original language description

    The idea of "repurposing" of existing drugs provides an effective way to develop and identify new therapies. Disulfiram (Antabuse), a drug commonly used for the treatment of alcoholism, shows promising anticancer activity in both preclinical and clinicalstudies. In the human body, disulfiram is rapidly converted to its reduced metabolite, diethyldithiocarbamate. If copper ions are available, a bis(diethyldithiocarbamate)-copper(II) complex is formed. Disulfiram's selective anticancer activity is attributed to the copper(II) complex's ability to inhibit the cellular proteasome. It is assumed that the complex inhibits the proteasome by a mechanism that is distinct to the clinically used drug bortezomib, targeting the 19S rather than the 20S proteasome.This difference could be explained by inhibition of the JAMM domain of the POH1 subunit within the lid of the 19S proteasome.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FR - Pharmacology and apothecary chemistry

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/EE.2.3.20.0062" target="_blank" >EE.2.3.20.0062: An inexpensive drug Antabuse as anticancer remedy: mechanism of action and clinical trials</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Mini - Reviews in Medicinal Chemistry

  • ISSN

    1389-5575

  • e-ISSN

  • Volume of the periodical

    12

  • Issue of the periodical within the volume

    12

  • Country of publishing house

    AE - UNITED ARAB EMIRATES

  • Number of pages

    9

  • Pages from-to

    1184-1192

  • UT code for WoS article

    000309058100003

  • EID of the result in the Scopus database